Page last updated: 2024-08-25

rosiglitazone and Dermatitis, Contact

rosiglitazone has been researched along with Dermatitis, Contact in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angeli, V; Capron, M; Hammad, H; Lambrecht, BN; Staels, B; Trottein, F1

Other Studies

1 other study(ies) available for rosiglitazone and Dermatitis, Contact

ArticleYear
Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.
    Journal of immunology (Baltimore, Md. : 1950), 2003, May-15, Volume: 170, Issue:10

    Topics: Animals; Cell Migration Inhibition; Cell Movement; Cells, Cultured; Cytokines; Dendritic Cells; Dermatitis, Contact; Epidermis; Female; Fluorescein-5-isothiocyanate; Haptens; Immunosuppressive Agents; Langerhans Cells; Lung; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Transgenic; Ovalbumin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Thorax; Transcription Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha

2003